SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflixs quarterly earnings report is the dominant focus, with traders debating whether guidance, subscriber engagement and ad growth can offset concerns about slowing growth and the content slate. Sentiment leans bearish amid the stocks decline and traders claims of repeated post-earnings selloffs, though some see low expectations as room for a rebound.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

A sharp rebound and heavy buying have fueled attention as traders anticipate the 80th-event trigger and final-analysis results for SELLASs Phase 3 REGAL trial of GPS. Some also read the CEOs anniversary remarks and planned ASH presence as possible buyout signals, but others stress there is no confirmed deal or trial result and that the price move may be trading activity.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceXs quarterly earnings and forward guidance are the dominant focus, particularly whether AI and data-center revenue can justify heavy capital spending. Traders are split between expecting a profitable report and rally and worrying about debt, spending, valuation, and an upcoming share unlock.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabets reported Willow quantum-computing advanceusing magic state cultivation to cut errors roughly 40-foldhas sparked interest, though traders question whether it will matter to the stock near term as the share price remains weak. Conversation also centers on the upcoming earnings report and whether the recent pullback is a buying opportunity or reflects broader tech and AI-spending concerns.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IRENs steep selloff is drawing attention amid broader funding and return concerns for AI-focused neoclouds, with traders also questioning the companys execution, dilution and delayed Horizon capacity. Co-CEO Daniel Roberts comments that data-center construction has been cash-funded and customer prepayments help finance GPUs are cited by bulls, but have not eased the bearish debate or frustration that IREN is lagging peers.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

SRPTs rise is being linked by traders both to strength across biotech and to the reported Silence Therapeutics acquisition, which some see as a sign of pharma interest in siRNA therapies relevant to Sareptas pipeline. Others view the move as a sector-driven bounce or short covering, and say upcoming DM1 and FSHD datanot a confirmed Sarepta-specific announcementwill be key.

Sea Ltd. is an internet and mobile platform company, which engages in the provision of online gaming services. It operates through the following segments: Digital Entertainment, E-Commerce, and Digital Financial Services. The Digital Entertainment segment offers and develops mobile and PC online games. The E-Commerce segment manages a third-party marketplace through the Shopee mobile app and websites that connect buyers and sellers. The Digital Financial Services segment includes a variety of payment services and loans to individuals and businesses through SeaMoney. Sea was founded by Xiao Dong Li, Gang Ye, and Jing Ye Chen on May 8, 2009 and is headquartered in Singapore.

Sea Ltd - ADR

Seas potential Monee fintech listing and launch of its Sea Cloud AI venture are fueling debate as shares sell off: some traders see a possible Monee separation and cloud investment as sources of uncertainty, while others argue the moves could unlock value and expand growth. The decline has intensified bearish technical commentary and speculation about insider selling, alongside bullish claims that the reaction is an overreaction.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

GM shares are falling despite a third-quarter earnings and revenue beat and a new buyback authorization, as investors focus on a narrowed full-year profit outlook with its midpoint unchanged rather than an upgrade. Traders are split between viewing the selloff as overdone given stronger cash-flow guidance and capital returns, and seeing the outlook and softer vehicle sales as reasons for caution.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is drawing attention as traders position around the detailed Phase 3 results for its personalized melanoma cancer vaccine with Merck at ESMO, following a positive topline readout. Bulls see the data as validation of its oncology platform, while skeptics warn that the sharp rally may have priced in strong results and could reverse on a sell-the-news reaction.

Alphabet Inc - Ordinary Shares - Class C

Alphabets upcoming earnings are the main focus, with traders watching Google Cloud and Gemini for signs of growth. The discussion is divided between optimism about AI and cloud momentum and concern that heavy AI spending, alongside recent share-price weakness, could weigh on returns.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

The Zacks Analyst Blog Highlights Alphabet, Mastercard, AbbVie, Perma-Pipe and ImmuCell

GOOGL, MA and ABBV headline today's research, with AI-led growth, electronic payments and strong drug portfolios shaping their outlooks.

Top Research Reports for Alphabet, Mastercard & AbbVie

Alphabet's AI-led cycle is strengthening Search, Cloud and subscriptions, while rising investment and regulatory risks create uncertainty around returns.

ImmuCell Stock Falls 8.8% Despite Y/Y Earnings & Sales Growth in Q2

ICCC's Q2 sales rise 11.5% y/y, but margins contract. A $2-million legal settlement boosts profit as the company plans a capacity expansion.

ImmuCell (ICCC) Q2 2026 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

ImmuCell Posts Strong Preliminary Q2 Sales on U.S. Demand

ICCC reports an 11.5% rise in preliminary Q2 sales, driven by robust U.S. demand and improved product availability, extending the momentum from its strong Q1 performance.

The Zacks Analyst Blog Highlights JPMorgan, Novartis, Qualcomm, Genie and ImmuCell  

Micron surged after strong Q3 results, robust AI-driven memory demand and a bullish Q4 outlook. See which ETFs have notable exposure.

Top Stock Reports for JPMorgan, Novartis & Qualcomm

JPMorgan, Novartis and Qualcomm headline today's top stock reports, highlighting growth drivers, competitive pressures and key catalysts ahead.

ICCC's Valuation Remains Premium: Is it Worth Overpaying for?

ImmuCell's premium valuation is backed by rising output, First Defense share gains and a sizable untapped calf-health market opportunity.

ImmuCell Q1 Earnings Rise Y/Y as Sales Climb on Strong Demand

ICCC posts record Q1 sales and 34% earnings growth as demand for its First Defense calf-health products boosts margins and market share.

ImmuCell Q1 Earnings Call Highlights

ImmuCell Corp. engages in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. It operates through the following segments: Scours and Mastitis. The Scours segment consists of the First Defense product line. The Mastitis segment includes the CMT product line consisting of reagents and equipment used for rapid cow-side testing to identify mastitic quarters by detecting elevated somatic cell counts. The company was founded in 1982 and is headquartered in Portland, ME.

Immucell Corp.

The Christmas Party Is Still Ongoing In These Stocks: Nvidia, Sidus Space, Coupang, Vanda Pharmaceuticals, ImmuCell

Equity

Bearish Sentiment

<ul class="summary-bullets"><li>Sidus Space shares continued to gain on Friday, up more than 22% in the midday session after the company was awarded a contract earlier this week under the Missile Defense Agency’s SHIELD program.</li><li>Coupang shares gained over 9% in Friday’s midday trade after the company stated that all leaked customer information has been deleted.</li><li>Vanda Pharmaceuticals shares gained nearly 8% in Friday’s pre-market trade before paring some of the gains to hover 3% higher, ahead of a pending FDA decision on its motion-sickness prevention drug, Tradipitant.</li></ul>U.S. equities traded in the green at noon on Friday as investors returned to the markets following the Christmas holiday on Thursday, with markets poised to end the week on a winning note.The Santa Claus rally began on Wednesday on a positive note, with the S&amp;P 500 notching a&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/sp-500-new-all-time-high-santa-claus-rally-begins-heading-into-christmas/cLetbEFREvm">new all-time high</a>.The&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF</a> (SPY), which mirrors the S&amp;P 500 index, was up 0.08% at the time of writing, while the&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust</a> (QQQ), which mirrors the Nasdaq 100 index, gained 0.16%. The&nbsp;<a href="https://stocktwits.com/symbol/DIA">SPDR Dow Jones Industrial Average ETF Trust</a> (DIA), which tracks the Dow Jones Industrial Average, rose 0.01%.<h2 class="st-heading-2">Here are the top stocks that are seeing the Christmas party continue:</h2><a href="https://stocktwits.com/symbol/NVDA">Nvidia Corp. (NVDA)</a>Nvidia’s shares were up nearly 2% in Friday’s midday trade after the company&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/nvidia-groq-deal-is-expensive-but-strategic-says-bofa/cLeUdL5REwf">entered</a> into a non-exclusive licensing agreement with Groq for its inference technology, with the deal value pegged at $20 billion.<a href="https://stocktwits.com/symbol/NVDA">NVDA stock</a> is up 10% over the past five trading sessions.<a href="https://stocktwits.com/symbol/SIDU">Sidus Space Inc. (SIDU)</a>Sidus Space shares continued to gain on Friday, up more than 22% in the midday session after the company was&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/sidus-space-stock-is-up-218-percent-this-month-retail-investors-still-bullish/cLeUaPpREws">awarded</a> a contract earlier this week under the Missile Defense Agency’s Scalable Homeland Innovative Enterprise Layered Defense (SHIELD) program.<a href="https://stocktwits.com/symbol/SIDU">SIDU stock</a> is up 237% over the past five trading sessions.<a href="https://stocktwits.com/symbol/CPNG">Coupang Inc. (CPNG)</a>Coupang shares gained over 9% in Friday’s midday trade after the company said that all the leaked customer information in a recent data breach had been deleted by the suspect, according to a Reuters&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/sustainability/boards-policy-regulation/coupang-says-all-leaked-customer-information-has-been-deleted-2025-12-25/">report</a>. Coupang stated that the suspect was a former employee.<a href="https://stocktwits.com/symbol/CPNG">CPNG stock</a> is up 10% over the past five trading sessions.<a href="https://stocktwits.com/symbol/VNDA">Vanda Pharmaceuticals Inc. (VNDA)</a>Vanda Pharmaceuticals shares gained nearly 8% in Friday’s pre-market trade before paring some of the gains to hover 3% higher,&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/vnda-stock-gains-ahead-of-fda-decision-next-week/cLeUERJREwX">ahead</a> of a pending U.S. Food and Drug Administration (FDA) decision on its motion-sickness prevention drug, Tradipitant.<a href="https://stocktwits.com/symbol/VNDA">VNDA stock</a> is up 7% over the past five trading sessions.<a href="https://stocktwits.com/symbol/ICCC">ImmuCell Corp. (ICCC)</a>ImmuCell shares were up nearly 10% in Friday’s midday trade after the company announced a 50% expansion of its First Defense field sales force and plans to scale up manufacturing of the drug. The company also said it is pausing its Re-Tain treatment for cows after receiving an “Incomplete Letter” from the FDA.<a href="https://stocktwits.com/symbol/ICCC">ICCC stock</a> is up 2% over the past five trading sessions.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/peter-schiff-gold-rally-here-to-stay-silver-new-high/cLeU3nTREwQ">Peter Schiff Says Investors Have Accepted Gold's Rally Is 'Here To Stay' As Silver Prices Soar To A Fresh High</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The Wall Street bull stands in the financial district near the New York Stock Exchange (NYSE) on November 18, 2025 in New York City. (Photo by Spencer Platt/Getty Images)

Nvidia shares were up nearly 2% in Friday’s midday trade after the company entered into a non-exclusive licensing agreement with Groq for its inference technology.

Coupang Inc

Sidus Space Inc - Ordinary Shares - Class A

Vanda Pharmaceuticals Inc

Double beat (rev + EPS)

Revenue beat, EPS miss

EPS beat, revenue miss

Double miss

SpaceX ($SPCX) reports earnings after the close today. What do you expect?

Stocktwits

) reports earnings after the close today. What do you expect?

Current Price	$10.42
Prev Close	$10.51
Open	$10.51
Dividend Yield	0.00%
50-Day Moving Average	$10.04
Beta	0.30
Avg. Volume	12,747.80
PE Ratio	125.27

52-Week High	$12.10
52-Week Low	$4.52
Market Capitalization	$95.45M
EPS (Annual)	-$0.1152
Price to Book	3.04
Revenue Per Employee	$378,687.32

Feed

News

Sentiment

Earnings

Fundamentals

Info

ICCC Fundamentals